about
Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2Selective targeting of the gamma1 isoform of protein phosphatase 1 to F-actin in intact cells requires multiple domains in spinophilin and neurabinThe neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunitsDiversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseIdentification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach.Screening for inhibitors of an essential chromatin remodeler in mouse embryonic stem cells by monitoring transcriptional regulation.Identification of small-molecule inhibitors of Trypansoma cruzi replication.Identification of a selective small molecule inhibitor of breast cancer stem cells.Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells.Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.Analysis of specific interactions of native protein phosphatase 1 isoforms with targeting subunits.Plain-language medical vocabulary for precision diagnosis.Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discoverySignificantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genesThe Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across speciesEncoding Clinical Data with the Human Phenotype Ontology for Computational Differential DiagnosticsIdentification of Small-Molecule Inhibitors of Trypansoma cruzi InfectionIdentification of Small-Molecule Inhibitors of Trypansoma cruzi Infection - Probe 1Identification of Small-Molecule Inhibitors of Trypansoma cruzi Infection - Probe 3Identification of Diversity-Oriented Synthesis Derived Small Molecule, ML341, with Cidal Activity Against Trypanosoma cruziIdentification of a Selective Small-Molecule Inhibitor of Breast Cancer Stem Cells - Probe 3Identification of a Selective Small-Molecule Inhibitor of Breast Cancer Stem Cells—Probe 2
P50
Q28569375-7D17975D-B861-4C44-849C-0BA77005FFF1Q28576940-826A898F-184F-4BC6-884F-E29064A695B6Q28582944-AE6366B7-463A-4EF4-97EE-A7547079D8F6Q33636200-238BAEDE-BCD4-4F5D-A9B3-CD07E83D57EAQ33883037-CF1121F3-98A6-411B-B939-1A79A8F37764Q33898400-C1B54199-3FD6-4383-893F-8DC0D962E26BQ34054192-4C42F3F5-DB4C-4A25-A5A6-481579239FD2Q34232314-3A99E95D-A0EE-4F01-A542-CEAA610C5A50Q34401291-AB424872-15BF-45D8-A9D4-47F43E6FF806Q34583383-2BC99906-4B41-4C2B-B09D-1CB12341205AQ35915829-2C082456-9115-4234-B77A-A3F02D58D294Q44692363-079E4B4F-45F7-43BD-ACC6-580078AA57E9Q52597747-D0EC87D8-4BC7-4C31-AE80-E7125E38342CQ64071540-CBCA0408-212F-4AC9-9E81-8B9A6D0D8A49Q89530747-56298EFD-3D2D-4419-9563-4C4A13FCC527Q91179320-CDC737CE-7DAC-4374-A497-9F50FEB78E74Q93074691-74235D03-8B5D-44FD-82EB-36FED6BC8D38Q95507857-E4E6C055-9A06-4F45-8061-1E66BC08CF83Q95519344-D354460E-3B9E-4AA8-9DB0-48ABEF0AA8A2Q95519379-9DC2370B-033B-4271-B54C-4FC1DE4D8142Q95521490-FAF7B9F4-7E06-4151-9814-FE803D7A6AC5Q95555696-2137C18D-2407-45C3-A922-4D6FF108712FQ95555719-01745E90-3180-4A83-9C69-542E9FF477F5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Leigh Carmody
@ast
Leigh Carmody
@en
Leigh Carmody
@es
Leigh Carmody
@nl
Leigh Carmody
@sl
type
label
Leigh Carmody
@ast
Leigh Carmody
@en
Leigh Carmody
@es
Leigh Carmody
@nl
Leigh Carmody
@sl
prefLabel
Leigh Carmody
@ast
Leigh Carmody
@en
Leigh Carmody
@es
Leigh Carmody
@nl
Leigh Carmody
@sl
P106
P31
P496
0000-0001-7941-2961